Transplacental Transfer and Biotransformation of Genistein in Human Placenta

被引:40
作者
Balakrishnan, B. [2 ,3 ]
Thorstensen, E. B. [2 ,3 ]
Ponnampalam, A. P. [2 ]
Mitchell, M. D. [1 ,2 ,3 ]
机构
[1] Queensland Ctr Clin Res, Brisbane, Qld 4029, Australia
[2] Univ Auckland, Liggins Inst, Auckland 1142, New Zealand
[3] Univ Auckland, Natl Res Ctr Growth & Dev, Auckland 1142, New Zealand
关键词
Genistein; Placental transfer; Placental perfusion; Genistein glucuronide; Endocrine disruptors; Phytoestrogens; RESISTANCE PROTEIN BCRP/ABCG2; FEMALE REPRODUCTIVE-SYSTEM; SOY ISOFLAVONE; PHYTOESTROGENS GENISTEIN; BISPHENOL-A; IN-VITRO; EXPRESSION; EXPOSURE; TRANSPORT; FETAL;
D O I
10.1016/j.placenta.2010.03.007
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Objective: To study transplacental transfer and biotransformation of genistein in the human placenta. Study design and outcomes: Human placentae obtained from healthy term singleton pregnancies were utilised in a dual re-circulating model of ex-vivo placental perfusion. Four placentae were perfused for 180 min following addition of genistein (10 ng/mL) to the maternal perfusate. Antipyrine and FITC dextran were used as positive and negative controls respectively to validate integrity of the circuits. Concentrations of genistein and its conjugates were determined by liquid chromatography-mass spectrometry (LC-MS). Results: The transfer percentage for antipyrine and genistein was 25.6 +/- 1.40% and 22.1 +/- 1.61% respectively and the transfer index for genistein was 0.90 +/- 0.04 after 180 min of perfusion. 12.0 +/- 2.40% of genistein in the fetal compartment and 7.36 +/- 4.73% of genistein in the maternal compartment were in the conjugated form. Conclusions: Genistein can transfer across the human placenta at environmentally relevant levels. Placental metabolizing enzymes conjugate a small fraction of genistein into the glucuronide/sulphate form, which is devoid of estrogenic action. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:506 / 511
页数:6
相关论文
共 50 条
[1]   Maternal and neonatal phytoestrogens in Japanese women during birth [J].
Adlercreutz, H ;
Yamada, T ;
Wähälä, K ;
Watanabe, S .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1999, 180 (03) :737-743
[2]   TRANSFER OF LIDOCAINE AND BUPIVACAINE ACROSS THE ISOLATED-PERFUSED HUMAN PLACENTA [J].
ALAKOKKO, TI ;
PIENIMAKI, P ;
HERVA, R ;
HOLLMEN, AI ;
PELKONEN, O ;
VAHAKANGAS, K .
PHARMACOLOGY & TOXICOLOGY, 1995, 77 (02) :142-148
[3]   Purified phytoestrogens in postmenopausal bone health: is there a role for genistein? [J].
Albertazzi, P .
CLIMACTERIC, 2002, 5 (02) :190-196
[4]   Transfer of bisphenol A across the human placenta [J].
Balakrishnan, Biju ;
Henare, Kimiora ;
Thorstensen, Eric B. ;
Ponnampalam, Anna P. ;
Mitchell, Murray D. .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2010, 202 (04) :393.e1-393.e7
[5]   MARKERS OF PHYSICAL INTEGRITY AND METABOLIC VIABILITY OF THE PERFUSED HUMAN PLACENTAL LOBULE [J].
CANNELL, GR ;
KLUCK, RM ;
HAMILTON, SE ;
MORTIMER, RH ;
HOOPER, WD ;
DICKINSON, RG .
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1988, 15 (11) :837-844
[6]   DEVELOPMENTAL EFFECTS OF ENDOCRINE-DISRUPTING CHEMICALS IN WILDLIFE AND HUMANS [J].
COLBORN, T ;
SAAL, FSV ;
SOTO, AM .
ENVIRONMENTAL HEALTH PERSPECTIVES, 1993, 101 (05) :378-384
[7]   Human placental glucuronidation and transport of 3′ azido-3′-deoxythymidine and uridine diphosphate glucuronic acid [J].
Collier, AC ;
Keelan, JA ;
van Zijl, PE ;
Paxton, JW ;
Mitchell, MD ;
Tingle, MD .
DRUG METABOLISM AND DISPOSITION, 2004, 32 (08) :813-820
[8]   Metabolizing enzyme localization and activities in the first trimester human placenta: the effect of maternal and gestational age, smoking and alcohol consumption [J].
Collier, AC ;
Tingle, MD ;
Paxton, JW ;
Mitchell, MD ;
Keelan, JA .
HUMAN REPRODUCTION, 2002, 17 (10) :2564-2572
[9]   UDP-glucuronosyltransferase activity, expression and cellular localization in human placenta at term [J].
Collier, AC ;
Ganley, NA ;
Tingle, MD ;
Blumenstein, M ;
Marvin, KW ;
Paxton, JW ;
Mitchell, MD ;
Keelan, JA .
BIOCHEMICAL PHARMACOLOGY, 2002, 63 (03) :409-419
[10]  
COUGHTRIE MWH, 1988, MOL PHARMACOL, V34, P729